Pharming Appoints Leverne Marsh and Kenneth Lynard as Interim Co-CEOs
Position
Chief Financial Officer
Company
Pharming Group
Description
Pharming has appointed Leverne Marsh and Kenneth Lynard as Interim Co-CEOs following the departure of Fabrice Chouraqui as CEO. This change aims to ensure continuity of leadership as the company searches for a permanent successor.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- ABIVAX Appoints New Chief Medical Officer and Chief Technical Officer (September 26, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Travere Therapeutics Appoints Bradley L. Campbell as Chief Executive Officer (September 21, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- AL-S Pharma Appoints Harry Welten as Chief Executive Officer (October 14, 2026)
Who to call at Pharming Group, and when
A new leader at Pharming Group brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Pharming Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pharming Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pharming Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pharming Group changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pharming Group changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.